Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot battle: which bronchoscope best snags lung nodules?

NCT ID NCT07411989

First seen Feb 21, 2026 · Last updated Jun 20, 2026 · Updated 22 times

Summary

This study compares two robotic bronchoscopy systems—Ion shape-sensing and Galaxy electromagnetic—to see which one is better at getting tissue samples from lung nodules. About 346 adults scheduled for a routine bronchoscopy will be randomly assigned to one of the two robots. The main goal is to see which system more often obtains a clear diagnosis, while also tracking radiation exposure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NODULES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • The Cleveland Clinic

    Cleveland, Ohio, 44195, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Robotic bronchoscopy (Ion shape-sensing or Galaxy electromagnetic system)

What this could lead to

If one system proves better at diagnosing lung nodules, it could become the preferred tool for lung cancer detection.

What could go wrong

This is an early-stage comparison study, not a treatment trial. It may not show a clear winner, and results might not apply to all patients or settings.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.